1887

Abstract

A polyclonal antiserum, raised against a pp71 fusion protein, was prepared in order to investigate the biosynthesis and localization of the matrix protein pp71 of human cytomegalovirus (HCMV), the UL82 gene product, during the HCMV infectious cycle in human fibroblasts. Transcription of the pp71-specific bicistronic 4.0 kb mRNA and pp71 biosynthesis exhibited a biphasic pattern during one round of the HCMV infectious cycle, with a first peak at 12 h and a second at 72 h post-infection (p.i.). Cycloheximide treatment of infected human fibroblasts revealed that the presence of pp71 in total cell extracts prior to 3 h p.i. was due to the input virus inoculum. Transcription of the two specific pp71 mRNAs commenced 5–7 h p.i. as shown by Northern blot analysis of total cellular RNA. Western blot analysis of isolated nuclei and indirect immuno-fluorescence experiments indicated that pp71, like the major tegument protein pp65, is present in the nucleus shortly after infection as well as during the late phase of viral morphogenesis. Also, after transient transfection of UL82 into U373MG cells, pp71 was found to be present in the nucleus of the transfected cells. By immunogold labelling, pp71 was detected in the nucleoplasm in association with nucleocapsids in electron-dense nuclear skein structures at late stages of the infection cycle. These findings suggest functions of pp71 in viral maturation in addition to that as an early transactivator of viral gene transcription described recently.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-77-12-3087
1996-12-01
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/77/12/JV0770123087.html?itemId=/content/journal/jgv/10.1099/0022-1317-77-12-3087&mimeType=html&fmt=ahah

References

  1. Alford C. A., Britt W. J. 1993; Cytomegalovirus. In The Human Herpesviruses pp 227–255 Edited by Roizman B., Whitley R. J., Lopez C. New York: Raven Press;
    [Google Scholar]
  2. Ausubel F., Brent R., Kingston R. E., Moore D. D., Seidman J. G., Smith J. A., Struhl K. 1989 Current Protocols in Molecular Biology New York: John Wiley & Sons;
    [Google Scholar]
  3. Brewer C. B. 1994; Cytomegalovirus plasmid vectors for permanent lines of polarized epithelial cells. Methods in Cell Biology 43:233–245
    [Google Scholar]
  4. Britt W. J., Auger D. 1986; Human cytomegalovirus virion- associated protein with kinase activity. Journal of Virology 59:185–188
    [Google Scholar]
  5. Chomczynski P., Sacchi N. 1987; Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 162:152–159
    [Google Scholar]
  6. Depto A. S., Stenberg R. M. 1989; Regulated expression of the human cytomegalovirus pp65 gene: octamer sequence in the promoter is required for activation by viral gene products. Journal of Virology 63:1232–1238
    [Google Scholar]
  7. Dingwall C., Laskey R. A. 1991; Nuclear targeting sequences - a consensus?. Trends in Biochemical Science 16:478–481
    [Google Scholar]
  8. Eggers M., Bogner E., Agricola B., Kern H. F., Radsak K. 1992; Inhibition of human cytomegalovirus maturation by brefeldin A. Journal of General Virology 73:2679–2692
    [Google Scholar]
  9. Fleckenstein B., Muller I., Collins J. 1982; Cloning of the complete human cytomegalovirus genome in cosmids. Gene 18:39–46
    [Google Scholar]
  10. Geballe A. P., Leach F. S., Mocarski . 1986; Regulation of cytomegalovirus late-gene expression: γ-genes are controlled by post-transcriptional events. Journal of Virology 57:864–874
    [Google Scholar]
  11. Gibson W. 1991; Cytomegalovirus protein structure and function. In Progress in Cytomegalovirus Research pp 357–370 Edited by Landini M. P. Amsterdam: Elsevier;
    [Google Scholar]
  12. Grefte J. M. M., van der Gun B. T. F., Schmolke S., van der Giessen M., van Son W. J., Plachter B., Jahn G., The T. H. 1992; The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection. Journal of General Virology 73:2923–2932
    [Google Scholar]
  13. Gupta P., St Jeor S., Rapp F. 1977; Comparison of the polypeptides of several strains of human cytomegalovirus. Journal of General Virology 34:447–454
    [Google Scholar]
  14. Harlow E., Lane D. 1988 Antibodies: A Laboratory Manual New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  15. Hensel G., Meyer H., Gartner S., Brand G., Kern H. F. 1995; Nuclear localization of the human cytomegalovirus tegument protein pp150 (ppUL32). Journal of General Virology 76:1591–1601
    [Google Scholar]
  16. Landini M. P., Severi B., Furlini G., Badiali de Giorgi L. 1987; Human cytomegalovirus structural components: intracellular and intraviral localisation of p28 and p65-69 by immunoelectron microscopy. Virus Research 8:15–23
    [Google Scholar]
  17. Lee W., Mitchell P., Tjian R. 1987; Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49:741–752
    [Google Scholar]
  18. Liu B., Stinski M. F. 1992; Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1 cis-acting elements. Journal of Virology 66:4434–4444
    [Google Scholar]
  19. Mocarski E. S. 1993; Cytomegalovirus biology and replication. In The Human Herpesviruses pp 173–226 Edited by Roizman B., Whitley R. J., Lopez C. New York: Raven Press;
    [Google Scholar]
  20. Montminy M. R., Bilazikjian L. M. 1987; Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene. Nature 328:175–178
    [Google Scholar]
  21. Nowak B., Gmeiner A., Sarnow P., Levine A., Fleckenstein B. 1984; Physical mapping of human cytomegalovirus genes: identification of DNA sequences coding for a virion phosphoprotein of 71 kDa and for a viral 65 kDa polypeptide. Virology 134:91–102
    [Google Scholar]
  22. Pande H., Baak S. W., Riggs A. D., Clark B. R., Shively J., Zaia J. A. 1984; Cloning and physical mapping of a gene fragment coding for a 64-kilodalton major late antigen of human cytomegalovirus. Proceedings of the National Academy of Sciences, USA 81:4965–4969
    [Google Scholar]
  23. Radsak K., Briicher H., Britt W., Shiou H., Schneider D., Kollert A. 1990; Nuclear compartmentation of glycoprotein B of human cytomegalovirus. Virology 177:515–522
    [Google Scholar]
  24. Radsak K. D., Briicher K. H., Georgatos S. D. 1991; Focal nuclear envelope lesions and specific nuclear Iamin A/C dephosphorylation during infection with human cytomegalovirus. European Journal of Cell Biology 54:299–304
    [Google Scholar]
  25. Revello M. G., Percivalle E., Di Matteo A., Morini F., Gerna G. 1992; Nuclear expression of the lower matrix protein of human cytomegalovirus in peripheral blood leukocytes of immunocompromised viraemic patients. Journal of General Virology 73:437–442
    [Google Scholar]
  26. Rixon F. J. 1993; Structure and assembly of herpesviruses. Seminars in Virology 4:135–144
    [Google Scholar]
  27. Roby C., Gibson W. 1986; Characterisation of phosphoproteins and protein kinase activity of virions, noninfectious enveloped particles, and dense bodies of human cytomegalovirus. Journal of Virology 59:714–727
    [Google Scholar]
  28. Riiger B., Klages S., Walla B., Albrecht J., Fleckenstein B., Tomlinson P., Barrell B. 1987; Primary structure and transcription of the genes coding for the two virion phosphoproteins pp65 and pp71 of human cytomegalovirus. Journal of Virology 61:446–453
    [Google Scholar]
  29. Schmolke S., Kern H. F., Drescher P., Jahn G., Plachter B. 1995a; The dominant phosphoprotein pp65 (UL83) of human cytomegalovirus is dispensable for growth in cell culture. Journal of Virology 69:5959–5963
    [Google Scholar]
  30. Schmolke S., Drescher P., Jahn G., Plachter B. 1995b; Nuclear targeting of the tegument protein pp65 (UL83) of human cytomegalovirus: an unusual bipartite nuclear localization signal functions together with other portions of the protein to mediate its efficient nuclear transport. Journal of Virology 69:1071–1078
    [Google Scholar]
  31. Scholl B. C., Von Hitzenstein J., Borisch B., Traupe B., Broker M., Jahn G. 1988; Prokaryotic expression of immunogenic polypeptides of the large phosphoprotein (pp150) of human cytomegalovirus. Journal of General Virology 69:1195–1204
    [Google Scholar]
  32. Severi B., Landini M. P., Govoni E. 1988; Human cytomegalovirus morphogenesis: an ultrastructural study of the late cytoplasmic phases. Archives of Virology 123:51–64
    [Google Scholar]
  33. Severi B., Landini M. P., Cenacchi G., Zini N., Maraldi N. M. 1992; Human cytomegalovirus nuclear and cytoplasmatic dense bodies. Archives of Virology 123:193–207
    [Google Scholar]
  34. Somogyi T., Michelson S., Masse M.-J. O. 1990; Genomic localisation of a human cytomegalovirus protein with protein kinase activity (PK68). Virology 174:276–285
    [Google Scholar]
  35. Spaete R. R., Gehrz R. C., Landini M. P. 1994; Human cytomegalovirus structural proteins. Journal of General Virology 75:3287–3308
    [Google Scholar]
  36. Stannard L. M., Hardie D. R. 1991; Am Fc receptor for human immunoglobulin G is located within the tegument of human cytomegalovirus. Journal of Virology 65:3411–3415
    [Google Scholar]
  37. Tooze J., Hollinshead M., Reis B., Radsak K., Kern H. 1993; Progeny vaccinia and human cytomegalovirus particles utilize early endosomal cistemae for their envelopes. European Journal of Cell Biology 60:163–178
    [Google Scholar]
  38. Wathen M. W., Stinski M. F. 1982; Temporal patterns of human cytomegalovirus transcription: mapping the viral RNAs synthesized at immediate early, early, and late times after infection. Journal of Virology 41:462–477
    [Google Scholar]
  39. Weiner D., Gibson W., Fields K. L. 1985; Anti-complement immunofluorescence establishes nuclear localization of human cytomegalovirus matrix protein. Virology 147:19–28
    [Google Scholar]
  40. Winkler M., Rice S. A., Stamminger T. 1994; UL69 of human cytomegalovirus, an open reading frame with homology to ICP27 of herpes simplex virus, encodes a transactivator of gene expression. Journal of Virology 68:3943–3954
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-77-12-3087
Loading
/content/journal/jgv/10.1099/0022-1317-77-12-3087
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error